News

Immunic, Inc. Reveals Conference Participation for May Events

Immunic, Inc. Reveals Conference Participation for May Events

Immunic, Inc. Announces Participation in Upcoming Conferences

Immunic, Inc. (Nasdaq: IMUX), an innovative biotechnology company, is gearing up for an exciting month of May as it participates in several significant scientific and industry conferences. The company focuses on developing a clinical pipeline of small molecule therapies, particularly targeting chronic inflammatory and autoimmune diseases. Through these events, Immunic aims to engage with experts and share valuable insights from its latest research.

Highlighting Scientific Contributions at Digestive Disease Week

From May 3-6, Immunic will present two abstracts at the Digestive Disease Week (DDW) conference. Held in San Diego, California, this event is known for gathering leading researchers in the field of gastroenterology. The first abstract, titled IMU-856 vs. Placebo Efficacy Effects in Celiac Disease Patients Are Independent of Q-MARSH Scale at Baseline, will be showcased to highlight findings from Immunic's phase 1/1b clinical trial of IMU-856, an oral modulator targeting SIRT6 for celiac disease management.

Details of the First Presentation

  • Abstract ID: 4216653
  • Poster Number: Tu1329
  • Presenting Author: Dr. Indira Pichetto Olanda
  • Session: Enteropathies — Celiac, Gluten Related and Environmental
  • Session Date: Tuesday, May 6
  • Session Time: 12:30 – 1:30 PM PDT

Another abstract titled Influence of Gut Epithelial Condition on the Pharmacokinetic Properties of IMU-856, an Oral Regulator of Barrier Function for the Treatment of Celiac Disease will also be presented, showcasing the promising results of this innovative treatment.

Details of the Second Presentation

  • Abstract ID: 4219364
  • Poster Number: Tu1344
  • Presenting Author: Dr. Jacques Arend
  • Session Date: Tuesday, May 6
  • Session Time: 12:30 – 1:30 PM PDT

Insights on Clinical Trial Supply at Clinical Trial Supply Forum

Following DDW, Immunic will participate in the Clinical Trial Supply Forum 2025 from May 13-15. This forum, which will take place in Brussels, Belgium, offers a platform for discussing challenges within the clinical trial supply chain. Kimi Oanh Le, Immunic’s Head of Clinical Trial Supply, will present a case study that delves into the supply chain challenges faced in the Middle East and North Africa (MENA) region.

Case Study Highlights

  • Case Study Title: Immunic Therapeutics Supply Chain Challenges Working Across MENA
  • Presentation Date: Wednesday, May 14
  • Time: 10:40 AM CEST (4:40 AM EDT)

Annual Meeting of the Consortium of Multiple Sclerosis Centers

Excitement doesn’t stop there. From May 28-31, Immunic's team will attend the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting 2025 in Phoenix, Arizona. The meeting comprises the latest advancements in multiple sclerosis treatments, and attendees can visit Immunic at booth #911. A poster presentation will spotlight the preclinical data of vidofludimus calcium (IMU-838), an innovative asset targeting neuroprotection in multiple sclerosis.

Poster Presentation Details

  • Poster Title: In Preclinical Models, Vidofludimus Calcium Exhibits Potential Neuroprotective Effects in Multiple Sclerosis by Modulating Nurr1
  • Presenting Author: Dr. Amelie Schreieck
  • Abstract ID: 10271
  • Poster Board Label: NDM01
  • Date: Thursday, May 29
  • Time: 5:00 – 7:00 PM MST

About Immunic, Inc.

Immunic, Inc. is dedicated to the advancement of new therapies for chronic inflammatory and autoimmune diseases. Their lead product, vidofludimus calcium (IMU-838), is currently in phase 3 clinical trials for treating relapsing multiple sclerosis, which shows promise in previous phases. This innovative product acts on the nuclear receptor related 1 (Nurr1) and exhibits both neuroprotective and anti-inflammatory effects.

Frequently Asked Questions

What events is Immunic participating in May?

Immunic is participating in Digestive Disease Week, Clinical Trial Supply Forum, and CMSC Annual Meeting.

What is IMU-856?

IMU-856 is an oral modulator targeting SIRT6, aimed at treating celiac disease and improving intestinal barrier function.

Who will present at the Clinical Trial Supply Forum?

Kimi Oanh Le, Immunic’s Head of Clinical Trial Supply, will present insights into supply chain challenges in the MENA region.

Where can I find presentations from the conferences?

All presentations will be available on Immunic's official website in the 'Events and Presentations' section.

What is Immunic’s focus in drug development?

Immunic focuses on small molecule therapies for chronic inflammatory and autoimmune diseases, particularly in areas such as multiple sclerosis.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hi3D Unlocks AI 3D Model for Open-Source Innovation

Updated Category News Views 4

A New Era in 3D Model Accessibility Unless you’ve been hiding under a rock, it’s hard to miss how digital terraforming has shifted gears. With Hi3D V1.0 opening its doors, the playing field's getting a major reshuffle. Or, as they say, the table is being set, and everyone's getting a seat. By letting loose production-validated AI tools, Hi3D is throwing down the...

Continue Reading
Full-Life's FL-020 Shows Promise for Prostate Cancer

Updated Category News Views 3

Breaking New Ground in Prostate Cancer Treatment You know, it’s not every day you stumble across news in the medical field that perks up the ears of investors, but let me tell ya, Full-Life Technologies' latest data drop has certainly caught my attention. If there’s even a smidge of truth in these findings, we might have a game-changer on our hands in the realm of...

Continue Reading
HawkEye 360 Expands with Advanced Satellite Launch

Updated Category News Views 4

Another Triumph for Signals Intelligence Launches come and go, but HawkEye 360's recent deployment of Cluster 16 isn't just another tick on their list. This satellite trio is kitted out with tech that propels the firm deeper into the realm of signals intelligence, where every second counts. The Art of Keeping Up with Demand Now, it's no simple feat to manage rocket...

Continue Reading
AHN Launches Cancer Screenings at Work; Dollar Bank First

Updated Category News Views 35

Pioneering Workplace Cancer Screening Initiative In a move that could redefine preventive healthcare, Allegheny Health Network (AHN) Cancer Center is taking cancer screenings right to the workplace. This initiative isn't just a new gimmick—it's a smart pivot in delivering healthcare where it's most convenient for employees. Here's looking at you, Dollar Bank, for being...

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 1

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading
VoxNexus Debuts On-Device AI: A Game-Changer for Languages

Updated Category News Views 0

VoxNexus Changes the Game with VoxEdge Here's the rub with tech: it often feels like it's only for the folks who already have a leg up. VoxNexus just flipped the script with its new product, VoxEdge, an on-device voice stack that's making waves by breaking language barriers in the ever-evolving AI world. This move might just shift the landscape of voice artificial...

Continue Reading
Corgi Invest Shakes Up Bond ETFs with Low Fees

Updated Category News Views 4

A Different Breed of Bond ETFs Well, folks, when you thought the ETF scene couldn't get any more crowded, Corgi Invest pops in with a pack of 14 new bond ETFs, barking up the low-expense tree like there's no tomorrow. They've dropped these puppies into the market with fees starting as low as 0.02%, aiming to take a bite out of their pricier rivals. The Alpha of Low-Cost...

Continue Reading
Harbour BioMed's Batoclimab Injected Into Myasthenia Market

Updated Category News Views 6

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 6

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading
Data Center Cooling Market to Hit $1B by 2033

Updated Category News Views 3

The Heat's On: Immersion Cooling Fluid Market Booms Kicking off with numbers straight out of the gate, data center immersion cooling fluids are gearing up for a wild ride. From just $0.23 billion back in 2026, this market is on a blitz to hit a whopping $1.06 billion by 2033. We're talking a hefty 24.8% compound annual growth rate. That's no small shakes. Race for Energy...

Continue Reading

Top 5 Most Recently Viewed Articles

United Therapeutics: Understanding Market Sentiment and Trends

Updated Category News Views 392

Market Sentiment Towards United Therapeutics United Therapeutics (NYSE: UTHR) has seen a notable increase in its short percent of float, rising to 7.82% since the last report. Currently, there are approximately 2.24 million shares sold short, equating to 6.62% of all regular shares available for trading. This trend indicates a growing cautious stance among some investors,...

Continue Reading
Canoe EIT Income Fund Reveals Monthly and Quarterly Distributions

Updated Category News Views 126

Canoe EIT Income Fund’s Distribution Announcements In the ever-evolving landscape of investment funds, the Canoe EIT Income Fund has made significant waves with its recent distribution announcements. The Fund, expertly managed and one of Canada’s premier closed-end investment opportunities, is prepared to offer a monthly distribution amounting to $0.10 per unit. This...

Continue Reading
ADMA Investors Evaluate Class Action Amidst Allegations

Updated Category News Views 9

Securities Fraud Allegations Cast Shadow Over ADMA Well, here we are again, wading through another mess in the biopharma world. This time, it's ADMA Biologics (NASDAQ: ADMA) in the spotlight, and not for their groundbreaking treatments. Nope, this one's about securities fraud allegations and, boy, do investors need to brace themselves. You got Berger Montague PC, those...

Continue Reading
Market Shifts: Navigating the Latest Trends in Trading

Updated Category News Views 266

Indices: An Overview of Uncertain Factors US equity index futures are stabilizing following a session marked by a remarkable rebound from previous lows, leading to higher closes for various indices. The S&P 500 rose by 0.4%, while the Nasdaq 100 surged up 0.7%, and the Dow 30 saw an increase of 0.5%. Notably, the small-cap Russell 2000 experienced the most significant...

Continue Reading
Primech A&P: A Trailblazer in Facility Management Excellence

Updated Category News Views 150

Primech A&P Achieves Prestigious Recognition in Facility Management With great pride, Primech Holdings Limited celebrates a significant milestone achieved by its subsidiary, Primech A&P Pte. Ltd. This notable recognition, the ASEAN Public Toilet Award, was presented in honor of Primech A&P's incredible management and upkeep of public facilities at Newton Food Centre....

Continue Reading